Allogene Therapeutics
ALLO
#8751
Rank
โ‚ฌ0.19 B
Marketcap
0,57ย โ‚ฌ
Share price
-5.88%
Change (1 day)
-46.42%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): -0,58ย โ‚ฌ

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,61ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,79ย โ‚ฌ an increase over its 2024 EPS that were of -1,21ย โ‚ฌ.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,58ย โ‚ฌ-27.37%
2025-0,79ย โ‚ฌ-34.59%
2024-1,21ย โ‚ฌ
2022-2,11ย โ‚ฌ22.75%
2021-1,72ย โ‚ฌ-9.13%
2020-1,90ย โ‚ฌ14.92%
2019-1,65ย โ‚ฌ-9.42%
2018-1,82ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,23ย โ‚ฌ 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA